Published in J Gastroenterol on April 26, 2007
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol (2009) 1.89
Liver diseases and metabolic syndrome. J Gastroenterol (2008) 1.33
A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice. J Clin Biochem Nutr (2008) 1.24
Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol (2009) 1.18
Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males. J Gastroenterol (2011) 0.96
Bofutsushosan, an Oriental Herbal Medicine, Attenuates the Weight Gain of White Adipose Tissue and the Increased Size of Adipocytes Associated with the Increase in Their Expression of Uncoupling Protein 1 in High-Fat Diet-Fed Male KK/Ta mice. J Clin Biochem Nutr (2008) 0.94
The effects of high-fat diet on the renal structure and morphometric parametric of kidneys in rats. J Anat (2008) 0.92
Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis. World J Gastroenterol (2009) 0.90
Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease. J Gastroenterol (2011) 0.90
Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males. J Gastroenterol (2011) 0.89
Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan. J Gastroenterol (2012) 0.87
Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population. J Gastroenterol (2010) 0.83
Visceral obesity as a risk factor for left-sided diverticulitis in Japan: a multicenter retrospective study. Gut Liver (2013) 0.83
Body mass index, smoking, and alcohol and risks of Barrett's esophagus and esophageal adenocarcinoma: a UK prospective cohort study. Dig Dis Sci (2014) 0.83
Erosive esophagitis associated with metabolic syndrome, impaired liver function, and dyslipidemia. World J Gastroenterol (2013) 0.81
Abdominal obesity as a risk factor for the development of erosive esophagitis in subjects with a normal esophago-gastric junction. Gut Liver (2009) 0.79
Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study. Middle East J Dig Dis (2014) 0.78
Obesity and gastrointestinal diseases. Gastroenterol Res Pract (2013) 0.76
Abdominal Visceral to Subcutaneous Adipose Tissue Ratio Is Associated with Increased Risk of Erosive Esophagitis. Dig Dis Sci (2017) 0.75
Association of medications for lifestyle-related diseases with reflux esophagitis. Ther Clin Risk Manag (2016) 0.75
Risk of Nongenitourinary Cancers in Patients With Spinal Cord Injury: A Population-based Cohort Study. Medicine (Baltimore) (2016) 0.75
Is Metabolic Syndrome Considered to Be a Risk Factor for Gastroesophageal Reflux Disease (Non-Erosive or Erosive Esophagitis)?: A Systematic Review of the Evidence. Iran Red Crescent Med J (2016) 0.75
Sarcopenia is associated with an increased risk of advanced colorectal neoplasia. Int J Colorectal Dis (2016) 0.75
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Prevalence and trends in obesity among US adults, 1999-2000. JAMA (2002) 33.23
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med (1996) 16.98
Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53
Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med (1992) 10.44
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42
Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest (1980) 5.11
Growth factors and cancer. Science (1991) 4.54
The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol (1997) 4.52
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 4.52
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst (1998) 3.66
Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology (2002) 3.26
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol (2000) 2.97
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (1995) 2.92
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst (1995) 2.83
Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2005) 2.82
Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA (1995) 2.68
Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc (2001) 2.68
The changing epidemiology of esophageal cancer. Semin Oncol (1999) 2.65
Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet (1985) 2.62
Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol (2005) 2.60
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 2.59
Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol (2003) 2.46
The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther (2005) 2.40
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control (1994) 2.33
The esophagogastric junction. N Engl J Med (1997) 2.32
Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut (1991) 2.29
The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol (1999) 2.26
Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev (1994) 2.23
Modifiable risk factors for colon cancer. Gastroenterol Clin North Am (2002) 2.21
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
The metabolic syndrome and risk of incident colorectal cancer. Cancer (2006) 2.16
Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol (2004) 2.09
Gastric emptying in patients with gastroesophageal reflux. Gastroenterology (1981) 2.02
Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis (2003) 1.98
Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. J Clin Endocrinol Metab (2006) 1.87
Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol (1999) 1.84
The relations of alcoholic beverage use to colon and rectal cancer. Am J Epidemiol (1988) 1.78
Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther (2006) 1.76
Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.75
Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol (2001) 1.72
Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus (2006) 1.63
Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut (2002) 1.57
Impaired egress rather than increased access: an important independent predictor of erosive oesophagitis. Neurogastroenterol Motil (2002) 1.55
Development of reflux esophagitis following Helicobacter pylori eradication. J Gastroenterol (2005) 1.53
Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2005) 1.49
Risk factors for Barrett's esophagus: a case-control study. Int J Cancer (2002) 1.49
Anthropometric correlates of intragastric pressure. Scand J Gastroenterol (2006) 1.43
Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. Ann Epidemiol (1999) 1.43
Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol (2001) 1.41
Elevated body mass disrupts the barrier to gastroesophageal reflux; discussion 1018-9. Arch Surg (2001) 1.37
Lifestyle factors and symptoms of gastro-oesophageal reflux -- a population-based study. Aliment Pharmacol Ther (2006) 1.36
Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther (2004) 1.33
Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obes Rev (2002) 1.30
Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control (1992) 1.27
Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg (1996) 1.27
Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res (1989) 1.26
Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) (2003) 1.19
Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2002) 1.14
Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J Gastroenterol Hepatol (2005) 1.13
Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sci (1995) 1.13
Gastroesophageal reflux in obese patients is not reduced by weight reduction. Scand J Gastroenterol (1996) 1.11
Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2004) 1.11
Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan. Am J Gastroenterol (2005) 1.10
Barrett's esophagus. Natural history, incidence, etiology, and complications. Gastroenterol Clin North Am (1991) 1.10
Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut (1992) 1.08
Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol (1993) 1.07
Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil (2006) 1.03
Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol (1999) 1.03
Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. Clin Gastroenterol Hepatol (2006) 1.00
Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer (1990) 1.00
Chemoprevention in gastrointestinal cancers: current status. Basic Clin Pharmacol Toxicol (2006) 0.95
Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg (2003) 0.94
Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J Gastroenterol (2005) 0.94
Gastrointestinal disorders and symptoms: does body mass index matter? Neth J Med (2006) 0.93
A prospective study of body mass, height, and smoking on the risk of colorectal cancer in women. Cancer Causes Control (1991) 0.93
Impaired glucose metabolism in colorectal cancer. Scand J Gastroenterol (2006) 0.89
Dietary epidemiology of cancer of the colon in western New York. Am J Epidemiol (1988) 0.87
Esophageal motility in Japanese patients with Barrett's esophagus. J Gastroenterol (2003) 0.86
Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol (2003) 0.86
Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis. Am J Gastroenterol (1994) 0.82
A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc (2003) 0.79
Multiple carcinoid tumors of the small intestine preoperatively diagnosed by double-balloon endoscopy. Med Sci Monit (2012) 1.44
Endoscopic submucosal dissection of large colorectal tumors by using a novel spring-action S-O clip for traction (with video). Gastrointest Endosc (2009) 1.38
Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol (2005) 1.24
Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol (2015) 1.08
Double-balloon endoscopy for treatment of long-term abdominal discomfort due to small bowel penetration by an eel bone. Med Sci Monit (2008) 1.07
A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol (2014) 1.01
Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up. Scand J Gastroenterol (2005) 0.99
Increased esophageal sensitivity to acid and saline in patients with nonerosive gastro-esophageal reflux disease. J Clin Gastroenterol (2006) 0.96
Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. J Gastroenterol Hepatol (2008) 0.94
Gastrointestinal stromal tumor of the stomach with a giant abscess penetrating the gastric lumen. World J Gastroenterol (2007) 0.94
Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J Gastroenterol (2005) 0.94
Metastatic renal cell carcinoma diagnosed by capsule endoscopy and double balloon endoscopy. Med Sci Monit (2011) 0.94
Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis. World J Gastroenterol (2009) 0.90
Presence of vertebral fractures is highly associated with hiatal hernia and reflux esophagitis in Japanese elderly people. Intern Med (2008) 0.90
Dissociation and dispersion of claudin-3 from the tight junction could be one of the most sensitive indicators of reflux esophagitis in a rat model of the disease. J Gastroenterol (2011) 0.90
A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan. Scand J Gastroenterol (2014) 0.90
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group). J Gastroenterol Hepatol (2014) 0.88
Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area. Helicobacter (2013) 0.88
Malignant lymphoma in the ileum diagnosed by double-balloon enteroscopy. World J Gastroenterol (2007) 0.88
Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS). BMC Gastroenterol (2012) 0.87
Use of selective serotonin reuptake inhibitors and upper gastrointestinal disease. Intern Med (2011) 0.87
Comparison of several activity indices for the evaluation of endoscopic activity in UC: inter- and intraobserver consistency. Inflamm Bowel Dis (2010) 0.86
Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito. BMC Gastroenterol (2014) 0.85
Prospective clinical trial of traction device-assisted endoscopic submucosal dissection of large superficial colorectal tumors using the S-O clip. Surg Endosc (2014) 0.85
Gastrointestinal hemorrhage as the first manifestation of metastatic extragonadal choriocarcinoma. Intern Med (2009) 0.85
The relationship between physical activity level and completion rate of small bowel examination in patients undergoing capsule endoscopy. Intern Med (2012) 0.84
Process of wound healing of large mucosal defect areas that were sutured by using a loop clip-assisted closure technique after endoscopic submucosal dissection of a colorectal tumor. Gastrointest Endosc (2013) 0.84
Usefulness of flexible spectral imaging color enhancement for the detection and diagnosis of small intestinal lesions found by capsule endoscopy. Scand J Gastroenterol (2014) 0.83
Clinical feature of asymptomatic reflux esophagitis in patients who underwent upper gastrointestinal endoscopy. J Gastroenterol Hepatol (2012) 0.82
A white opaque substance-positive gastric hyperplastic polyp with dysplasia. World J Gastroenterol (2013) 0.82
Evaluation of new subclassification of type V(I) pit pattern for determining the depth and type of invasion of colorectal neoplasm. J Gastroenterol (2010) 0.82
The 'Loop Clip' is useful for closing large mucosal defects after colorectal endoscopic submucosal dissection: a preliminary clinical study. Dig Endosc (2011) 0.82
Obstructing small bowel bezoars due to an agar diet: diagnosis using double balloon enteroscopy. Intern Med (2008) 0.81
Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen. J Gastroenterol (2004) 0.81
Reactive lymphoid hyperplasia of the liver associated with primary biliary cirrhosis. Med Sci Monit (2010) 0.81
Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan. J Gastroenterol Hepatol (2006) 0.81
Eradication of Helicobacter pylori in hemodialysis patients. Ren Fail (2007) 0.81
Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia. J Gastroenterol Hepatol (2010) 0.81
Corticotropin-releasing factor secretion from dendritic cells stimulated by commensal bacteria. World J Gastroenterol (2011) 0.80
Relationship between endoscopic findings and clinical severity in ischemic colitis. Intern Med (2011) 0.80
Intestinal involvement in Wegener's granulomatosis diagnosed and followed up by double balloon enteroscopy. Intern Med (2011) 0.80
Clinicopathological features of nonpolypoid colorectal tumors as viewed from the patients' background. J Gastroenterol (2006) 0.79
Frequent occurrence of fever in patients who have undergone endoscopic submucosal dissection for colorectal tumor, but bacteremia is not a significant cause. Surg Endosc (2014) 0.79
Development and clinical usability of a new traction device "medical ring" for endoscopic submucosal dissection of early gastric cancer. Surg Endosc (2013) 0.79
Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Digestion (2003) 0.79
Colonic mucosal lesions associated with long-term or short-term administration of nonsteroidal anti-inflammatory drugs. Colorectal Dis (2010) 0.78
Efficacy of Lansap combination therapy for eradication of H. pylori. Helicobacter (2007) 0.78
Clinicopathological characteristics of colorectal cancer less than 10 mm in diameter and invading submucosa and below. J Gastroenterol Hepatol (2010) 0.78
Specific induction of a 72-kDa heat shock protein protects esophageal mucosa from reflux esophagitis. Life Sci (2009) 0.78
[GERD and tight junction proteins of the esophageal mucosa]. Nihon Rinsho (2004) 0.78
Jejunal capillary hemangioma treated by using double-balloon endoscopy (with video). Gastrointest Endosc (2010) 0.77
Target molecules of molecular chaperone (HSP70 family) in injured gastric mucosa in vivo. Life Sci (2009) 0.77
Location of early colorectal cancers at fold-top may reduce the risk of lymph node metastasis. Dis Colon Rectum (2006) 0.77
Analysis of brain activity during visceral stimulation. J Gastroenterol Hepatol (2012) 0.77
Evaluation of EORTC QLQ-C30 questionnaire in patients undergoing in-hospital chemotherapy for gastrointestinal cancer in Japan. J Gastroenterol Hepatol (2008) 0.77
Current perspectives on reflux laryngitis. Clin J Gastroenterol (2014) 0.76
Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'. Digestion (2013) 0.76
Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population. Helicobacter (2002) 0.76
Inhibition of cell proliferation and induction of apoptosis by Helicobacter pylori through increased phosphorylated p53, p21 and Bax expression in endothelial cells. J Med Microbiol (2002) 0.75
Colonic mucosal lesions associated with low-dose aspirin: a case control study. Scand J Gastroenterol (2011) 0.75
Metastatic seminoma in the duodenum: diagnosis with endoscopy followed by successful treatment. Intern Med (2014) 0.75
Response to chemotherapy in a case of gastric adenocarcinoma producing granulocyte colony-stimulating factor. Med Sci Monit (2010) 0.75
Diaphragm-like stricture in the duodenum in a patient with systemic sclerosis: unrelated to non-steroidal anti-inflammatory drug use. Intern Med (2007) 0.75
Advanced colorectal cancer with double-hump camel-like appearance. Dig Endosc (2011) 0.75
[Diseases of the digestive system and Kanpo: discussion]. Nihon Shokakibyo Gakkai Zasshi (2010) 0.75
[Q & A. Case of metastatic cancer discovered at the detection of melena]. Nihon Shokakibyo Gakkai Zasshi (2012) 0.75
A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia. Digestion (2017) 0.75
[Pharmacological therapy of functional dyspepsia]. Nihon Shokakibyo Gakkai Zasshi (2012) 0.75
[Digestive organ diseases and metabolic syndrome]. Nihon Shokakibyo Gakkai Zasshi (2008) 0.75
[Q & A: peritonitis resistant to treatment with antitubercular agents]. Nihon Shokakibyo Gakkai Zasshi (2010) 0.75
Endoscopic mucosal resection using a cap-fitted panendoscope as a diagnostic procedure in a case of scirrhous gastric carcinoma. Dig Endosc (2012) 0.75
Pretreatment prediction of symptom response to proton pump inhibitor therapy. J Gastroenterol Hepatol (2015) 0.75
[Case of computed tomography (CT) gastrography for the detection of multiple gastric submucosal tumors: a case report]. Nihon Shokakibyo Gakkai Zasshi (2014) 0.75
Gastrointestinal tuberculosis as a cause of massive bleeding. Med Sci Monit (2009) 0.75
[Current topics related to the management of functional dyspepsia: discussion]. Nihon Shokakibyo Gakkai Zasshi (2012) 0.75
Establishment of a reflux esophago-laryngitis model in rats. Dig Dis Sci (2010) 0.75
[Second-line therapy for Helicobacter pylori]. Nihon Rinsho (2013) 0.75
[Q & A. The disease suggested by diagnostic imaging]. Nihon Shokakibyo Gakkai Zasshi (2013) 0.75